VRTX

Vertex Pharmaceuticals Incorporated · Healthcare · Biotechnology
$447.54
-0.43 (-0.10%)
Mkt Cap: 113.59B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield2.8%
Dividend YieldN/A
Market Cap113.59B
Volume1.41M
Recent News
Vertex Pharmaceuticals Incorporated (VRTX) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
seekingalpha.com · 2026-05-29
These 2 Cheap Biotech Stocks Offer Potential for Low-Beta Growth
247wallst.com · 2026-05-28
Vertex Pharmaceuticals Incorporated (VRTX) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
seekingalpha.com · 2026-05-19
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
zacks.com · 2026-05-19
VRTX's Alyftrek, Journavx & Casgevy See Strong Momentum in Q1 Earnings
zacks.com · 2026-05-08
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know
zacks.com · 2026-05-08

Unlock the Full Deep Scan

9 AI agents analyze VRTX across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →